IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
First-Line
Chronic Lymphocytic Leukemia Research Consortiummonoclonal_antibodyPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the First-Line cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin Danish Oncological Lung Cancer Group | Phase 3 | B |
CIS-DIAMMINEDICHLOROPLATINUM II Danish Oncological Lung Cancer Group | Phase 3 | B |
ETOPOSIDE Danish Oncological Lung Cancer Group | Phase 3 | B |
Hycamtin Danish Oncological Lung Cancer Group | Phase 3 | B |
cc-5013 Chronic Lymphocytic Leukemia Research Consortium | Phase 2 | CCC |
View all 9 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →